Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Immunogenicity Have an Influence on the Efficacy of Anti-tumor Necrosis Factor (Anti-TNF) Therapy in Patients With Ankylosing Spondylitis (AS): An Inception Cohort Study

NCT02687620 is registered in ClinicalTrials.gov with Izmir Katip Celebi University as lead sponsor.

NCT NCT02687620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02687620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Immunogenicity Have an Influence on the Efficacy of Anti-tumor Necrosis Factor (Anti-TNF) Therapy in Patients With Ankylosing Spondylitis (AS): An Inception Cohort Study
Lead sponsor
Izmir Katip Celebi University
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2014
Completion date
April 30, 2021
Enrollment
180 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, axial spondyloarthritis